Archives
  • New CRISPR Experiment Corrects Clotting in Mice

    The future of gene editing is slowly approaching great promise. Recent developments surrounding CRISPR/Cas9 showed its efficiency and promise in correcting disease-causing mutations. For the first time, it was used to develop a dual gene therapy to treat hemophilia B in mice, which normally leads to a defective clotting protein.